Bronchiectasis

November 19, 2014November 6, 2015

Intravenous Antibiotics For Bronchiectasis Administered at Home Shows Promising Results

Bronchiectasis, News

A new prospective cohort study on the use of domiciliary intravenous (IV) antibiotic therapy in patients with non-cystic fibrosis bronchiectasis entitled “A prospective cohort study of the use of domiciliary ... Read more

November 18, 2014November 6, 2015

Tailored Treatment is Successful for CVID Patients with Bronchiectasis

Bronchiectasis, News

Often times, clinicians are unconcerned with the cause of bronchiectasis in patients. Clinicians usually diagnose a patient with post-infective or idiopathic bronchiectasis, and the different diagnoses have minimal impact on ... Read more

November 17, 2014November 6, 2015

Cystic Fibrosis, Non-Cystic Fibrosis Bronchiectasis Lung Ventilation Abnormalities Revealed Through MRI Technique

Bronchiectasis, News

Gregory Paulin and colleagues from Robarts Research Institute and The University of Western Ontario, Canada, presented results in an abstract of a pilot study aimed at examining the relationship between ... Read more

November 13, 2014November 6, 2015

New MRI Approach Reveals Bronchiectasis’ Key Features Within the Lung

Bronchiectasis, News

In an abstract presented during American Thoracic Society 2014 International Conference, entitled “Pulmonary Functional Imaging Of Bronchiectasis: A First Look At Ventilation Abnormalities And Their Relationship With Pulmonary Function And ... Read more

October 3, 2014November 11, 2015

Robarts Research Institute Confirms Aerobika OPEP Effectiveness in the Treatment of COPD and Bronchiectasis

Bronchiectasis, COPD, News

A recent study conducted at the Robarts Research Institute at Western University in London, UK, demonstrated the effectiveness of the drug-free Aerobika device for the treatment of both chronic obstructive pulmonary disease (COPD) ... Read more

September 24, 2014November 6, 2015

Pseudomonas Leads to Bronchiectasis By Distracting Antibodies

Bronchiectasis, News

One of the obstacles that pharmaceutical companies and researchers face in the development of new therapeutics is bacterial mutation. Some medications take, on average, a decade of testing and rigorous ... Read more

September 16, 2014November 6, 2015

Progress in Superior Treatments for Superbugs Could Impact Pneumonia, Bronchiectasis & Cystic Fibrosis Patients

Bronchiectasis, Cystic Fibrosis, News

A team of researchers from the Agency for Science, Technology and Research’s (A*STAR) Institute of Chemical and Engineering Sciences (ICES) and the National University Hospital (NUH) is working toward returning ... Read more

September 12, 2014November 6, 2015

Pharmaxis to Present New Data on Bronchiectasis Study at European Respiratory Society

Bronchiectasis

Pharmaceutical company Pharmaxis announced that it has presented new data from its large scale study of Bronchitol, called B305, and conducted in patients with bronchiectasis, at the European Respiratory Society (ERS), which took take ... Read more

September 10, 2014November 6, 2015

Aradigm’s Novel Non-Cystic Fibrosis Bronchiectasis Treatment Granted Fast Track Status by FDA

Bronchiectasis, News

The pharmaceutical company Aradigm Corporation received Fast Track status for its lead product candidate, Pulmaquin, from the U.S. Food and Drug Administration. The drug, which is being studied for treatment of non-cystic ... Read more

August 5, 2014November 6, 2015

Aradigm Doses First Patient in Second Phase III Study of Pulmaquin in Non-Cystic Fibrosis Bronchiectasis

Bronchiectasis, News

Aradigm Corporation announced the dosing of the first patient in a Phase III pivotal clinical trial that is testing Pulmaquin, an inhaled ciprofloxacin formula. ORBIT-4 is the second of two trials ... Read more